by John Marlott | Oct 18, 2018 | Final Written Decisions, Request for Reconsideration, Trial Institution
By T. Kaitlin Crowder, John Marlott, and Dave Cochran The PTAB may institute IPR proceedings only on the basis of certain prior art that is potentially invalidating under § 102 (novelty) or § 103 (obviousness). The PTAB may not institute IPR on any other...
by Carl Kukkonen | Feb 5, 2018 | Estoppel, Federal Circuit, Federal Circuit Appeal, Request for Reconsideration
By: Amanda Leckman and Carl Kukkonen Eleven days after the Federal Circuit’s en banc opinion in Wi-Fi Onc, LLC v. Broadcom Corp., Nos. 15-1944, -1945 & -1946 (Fed. Cir. Jan. 8, 2018), a three-judge panel granted a petition by patent owner Click-to-Call...
by Jones Day's PTAB Team | Sep 21, 2017 | Request for Reconsideration
By J. Jason Williams and J. Patrick Elsevier, Ph.D. In Coalition For Affordable Drugs VI, LLC v. Celgene Corp. (2015-01096, -01102, -01103),[1] the PTAB granted Patent Owner Celgene’s request for rehearing of a final written decision that had found the challenged...
by Carl Kukkonen | Feb 14, 2017 | Claim Construction, Request for Reconsideration
By Kamilah Alexander and Carl Kukkonen Conventional wisdom endorses the view that petitioning for a rehearing of a Patent Trial and Appeal Board (“Board”) final written decision is a waste of both attorney and client resources (i.e., time and money). Does...
by Jones Day's PTAB Team | Dec 20, 2016 | Pharmaceutical, Request for Reconsideration
By Lisamarie LoGiudice, Ph.D. and Cary Miller, Ph.D. In Mylan Pharmaceuticals Inc. and Amneal Pharmaceuticals LLC v. Yeda Research & Development Co. Ltd., IPR2015-00643; -00644; -00830, the PTAB granted-in-part Patent Owner Teva’s request for rehearing of the...
